EP2610343 - Method for designing siRNA and oligoribonucleotides inhibiting HCV [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 31.07.2015 Database last updated on 15.06.2024 | Most recent event Tooltip | 31.07.2015 | Application deemed to be withdrawn | published on 02.09.2015 [2015/36] | Applicant(s) | For all designated states Chugai Seiyaku Kabushiki Kaisha 5-1, Ukima 5-chome Kita-ku Tokyo 115-8543 / JP | For all designated states Tokyo Metropolitan Institute of Medical Science 2-1-6, Kamikitazawa Setagaya-ku Tokyo 156-8506 / JP | [2013/27] | Inventor(s) | 01 /
Kohara, Michinori c/o Tokyo Metropolitan Institute of Medical Science 1-6, Kamikitazawa 2-chome Setagaya-ku Tokyo 156-8506 / JP | 02 /
Sudo, Masayuki c/o Chugai Seiyaku Kabushiki Kaisha 200 Kajiwara Kamakura-shi Kanagawa 247-8530 / JP | [2013/42] |
Former [2013/27] | 01 /
Kohara, Michinori c/o Tokyo Metropolitan Institute of Medical Science 1-6, Kamikitazawa 2-chome Setagaya-ku Tokyo 1568506 / JP | ||
02 /
Sudo, Masayuki c/o CHUGAI SEIYAKU KABUSHIKI KAISHA 200 Kajiwara, Kamakura-shi Kanagawa 247-8530 / JP | Representative(s) | Bösl, Raphael Konrad Patentanwälte Isenbruck Bösl Hörschler PartG mbB Eastsite One Seckenheimer Landstraße 4 68163 Mannheim / DE | [N/P] |
Former [2013/27] | Bösl, Raphael Konrad Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstrasse 68 81675 München / DE | Application number, filing date | 13001670.2 | 26.11.2009 | [2013/27] | Priority number, date | JP20080301764 | 26.11.2008 Original published format: JP 2008301764 | [2013/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2610343 | Date: | 03.07.2013 | Language: | EN | [2013/27] | Type: | A3 Search report | No.: | EP2610343 | Date: | 25.09.2013 | Language: | EN | [2013/39] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 28.08.2013 | Classification | IPC: | C12N15/113 | [2014/47] | CPC: |
C12N15/1131 (EP,US);
C12N15/113 (US);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/16 (EP);
A61P31/18 (EP);
|
Former IPC [2013/27] | C12N15/113, C12N15/11 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2013/27] | Title | German: | VERFAHREN ZUM ENTWURF VON SIRNA UND OLIGORIBONUKLEOTIDE ZUR HEMMUNG DER AKTIVITÄT DES HEPATITIS-C-VIRUS | [2013/27] | English: | Method for designing siRNA and oligoribonucleotides inhibiting HCV | [2013/27] | French: | PROCEDE DE DESIGN DE SIRNA ET OLIGORIBONUCLÉOTIDES CAPABLE D'INHIBER L'ACTIVITÉ DU VIRUS DE L'HÉPATITE C | [2013/27] | Examination procedure | 13.12.2013 | Amendment by applicant (claims and/or description) | 13.12.2013 | Examination requested [2014/04] | 17.02.2014 | Despatch of a communication from the examining division (Time limit: M02) | 01.04.2014 | Reply to a communication from the examining division | 30.10.2014 | Communication of intention to grant the patent | 10.03.2015 | Application deemed to be withdrawn, date of legal effect [2015/36] | 15.04.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2015/36] | Parent application(s) Tooltip | EP09829126.3 / EP2368989 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 17.02.2014 | Fees paid | Renewal fee | 27.03.2013 | Renewal fee patent year 03 | 27.03.2013 | Renewal fee patent year 04 | 28.11.2013 | Renewal fee patent year 05 | 25.11.2014 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2005110067 (INVITROGEN CORP [US], et al) [A] 1-9 * examples 1-3 *; | [A] - CHEVALIER CHRISTOPHE ET AL, "Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA, US, (20070801), vol. 15, no. 8, doi:10.1038/SJ.MT.6300186, ISSN 1525-0016, pages 1452 - 1462, XP009095520 [A] 1-9 * the whole document * DOI: http://dx.doi.org/10.1038/sj.mt.6300186 | [A] - ALEXANDER V. VLASSOV ET AL, "shRNAs Targeting Hepatitis C: Effects of Sequence and Structural Features, and Comparision with siRNA", OLIGONUCLEOTIDES, (20070601), vol. 17, no. 2, doi:10.1089/oli.2006.0069, ISSN 1545-4576, pages 223 - 236, XP055035981 [A] 1-9 * the whole document * DOI: http://dx.doi.org/10.1089/oli.2006.0069 | [AD] - WATANABE, T. ET AL., GENE THERAPHY, (2006), vol. 13, pages 883 - 892, XP002495218 [AD] 1-9 * the whole document * | [A] - M. GIMENEZ-BARCONS ET AL, "Endoribonuclease-Prepared Short Interfering RNAs Induce Effective and Specific Inhibition of Human Immunodeficiency Virus Type 1 Replication", JOURNAL OF VIROLOGY, (20071001), vol. 81, no. 19, doi:10.1128/JVI.00950-07, ISSN 0022-538X, pages 10680 - 10686, XP055060413 [A] 1-9 * the whole document * DOI: http://dx.doi.org/10.1128/JVI.00950-07 | by applicant | WO2004078974 | - FIRE, A. ET AL., NATURE, (1998), vol. 391, pages 806 - 811 | - TSUKIYAMA-KOHARA K. ET AL., J.VIROLOGY, (1992), vol. 66, pages 1476 - 1483 | - KATO. N. ET AL., PROC. NATL. ACAD. SCI. USA., (1990), vol. 87, pages 9524 - 9528 | - PROC. NATL. ACAD. SCI. USA., (1991), vol. 88, pages 2451 - 2455 | - J. VIOL., (1991), vol. 65, pages 1105 - 1113 | - J. GEN. VIOL., (1991), vol. 72, pages 2697 - 2704 | - VIROLOGY, (1992), vol. 188, pages 331 - 341 | - HONDA MASAO. ET AL., J.VIROL., (1999), vol. 73, pages 1165 - 1174 | - HONDA MASAO ET AL., RNA, (1996), vol. 2, no. 10, pages 955 - 968 | - SASANO T. ET AL., GENOME INF. SER., (1998), vol. 9, pages 395 - 396 | - ITO T ET AL., J. VIROL., (1998), vol. 72, pages 8789 - 8796 | - KAMOSHITA N ET AL., VIROLOGY, (1997), vol. 233, pages 9 - 18 | - WATANABE, T. ET AL., GENE THERAPHY, (2006), vol. 13, pages 883 - 892 | - PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 5873 - 5877 | - ALTSCHUL ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410 | - SAMBROOK, J. ET AL., Molecular Cloning, COLD SPRING HARBOR LAB. PRESS, (1989), vol. 9, pages 47 - 9.58 | - KATO N. ET AL., PROC. NATL. ACAD. SCI. USA., (1990), vol. 87, pages 9524 - 9528 | - TSUKIYAMA; KOHARA ET AL., J. VIROL., (1992), vol. 66, pages 1476 - 1483 | - HONDA MASAO ET AL., J. VIROL., (1999), vol. 73, pages 1165 - 1174 | - KAMOSHITA N ET AL., VIROLOGY., (1997), vol. 233, pages 9 - 18 | - NIELSEN PETER E., METHODS IN MOLECULAR BIOLOGY, (2002), vol. 208, pages 3 - 26 | - BRAASCH DWAINE A ET AL., BIOCHEMISTRY, (2002), vol. 41, no. 14, pages 4503 - 4510 | - KOPPELHUS UFFE ET AL., ANTISENSE DRUG TECHNOLOGY, (2001), pages 359 - 374 | - NIELSEN PETER E., METHODS IN ENZYMOLOGY, (2001), vol. 340, pages 329 - 340 | - NATURE BIOTECH, (2002), vol. 19, pages 497 - 500 | - Y. NIITSU ET AL., MOLECULAR MEDICINE, (1998), vol. 35, pages 1385 - 1395 | - ZANTA M. A. ET AL., "Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus", PROC NATL ACAD SCI U S A., (19990105), vol. 96, no. 1, doi:doi:10.1073/pnas.96.1.91, pages 91 - 6, XP002104949 DOI: http://dx.doi.org/10.1073/pnas.96.1.91 | - LIU F; HUANG L, "Improving plasmid DNA-mediated liver gene transfer by prolonging its retention in the hepatic vasculature", J. GENE MED., (200111), vol. 3, no. 6, pages 569 - 76 | - SMITH, N.A. ET AL., NATURE, (2000), vol. 407, page 319 | - WESLEY, S.V. ET AL., PLANT J., (2001), vol. 27, page 581 | - PICCIN, A. ET AL., NUCLEIC ACIDS RES., (2001), vol. 29, page E55 | - BERNSTEIN, E. ET AL., NATURE, (2001), vol. 409, pages 363 - 366 | - HAMMOND, S. M. ET AL., NATURE, (2000), vol. 404, pages 293 - 296 | - YUKI NAITO ET AL., RETROVIROLOGY, (2007), vol. 4, page 80 | - SATOSHI SEKIGUCHI; YOSHIMI TOBITA; MICHINORI KOHARA, "C-gata kan-en virus no Jizokukansenkikou to Byogensei (persistent infection mechanism and pathogenesis of hepatitis C virus", MEDICAL SCIENCE DIGEST., (2009), vol. 35, no. 6, pages 14 - 17 |